Cleveland BioLabs, Inc. (NASDAQ:CBLI)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

Recs

0
Player Avatar spiellman (< 20) Submitted: 2/12/2007 5:51:03 PM : Outperform Start Price: $8.75 CBLI Score: -83.89

Fat government contracts coming down the pipeline.

Featured Broker Partners


Advertisement